2017 AAHKS Annual Meeting

The following abstracts were presented at the podium during the 2017 AAHKS Annual Meeting from November 2-5, 2017 at the Hilton Anatole in Dallas. Download the PDF of the Final Program Book and download the final list of disclosures.

AAHKS Awards

The James A. Rand Young Investigator’s Award

Battling the Opioid Epidemic with Prospective Pain Threshold Measurement
Brian T. Nickel, MD
Co-Authors: Mitchell R. Klement, MD, William A. Byrd, MD, David E. Attarian, MD, Thorsten M. Seyler, MD, PhD, Samuel S. Wellman, MD

The Lawrence D. Dorr Surgical Techniques & Technologies Award

“Running Two Rooms” Does Not Compromise Outcomes or Patient Safety in Total Joint Arthroplasty
William G. Hamilton, MD
Co-Authors: Henry Ho, MS, Nancy L. Parks, MS, James F. McDonald, III, BS, Robert H. Hopper, Jr., PhD, Nitin Goyal, MD, Kevin B. Fricka, MD, C. Anderson Engh, MD

The AAHKS Clinical Research Award

Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial
Simon W. Young, MBChB, FRCS
Co-Authors: Joon Chin, MBBS, Grant Moore, BS, Mei Zhang, PhD, Henry D. Clarke, MD, Mark J. Spangehl, MD

Podium Abstracts in Order of Presentation

1. 1. 1. Mobile Patient Engagement Platforms May Help Reduce 30-Day Readmission Rates in Arthroplasty Patients
         Stefano A. Bini, MD
      2. Low-Dose Aspirin is as Safe and Effective a Prophylaxis as High-Dose Aspirin for Venous Thromboembolism after Total Hip Arthroplasty
         Mahmad Faour, MD
      3. Tranexamic Acid in Total Joint Arthroplasty: Safe and Effective for All Patients?
         Yale A. Fillingham, MD
      4. Complications and Mortality Following Total Hip Arthroplasty in Octogenarians: An Analysis of a National Database
         Anthony J. Boniello, MD
      5. Race, Medicaid insurance, BMI and Female Gender Correlated with Consistently Lower HOOS JR Scores
         Brian A. Klatt, MD
      6. Press Ganey Patient Satisfaction Scores do not Correlate with Patient Reported Outcomes after Joint Replacement
         Jeremy M. Gililland, MD
      7. Psychological Factors Associated with Failure to Complete a Short-Stay Total Hip Arthroplasty Protocol
         Mark A. Oyer, MD
      8. Treated vs. Un-Treated Depression in Total Joint Arthroplasty Impacts Outcomes
         Christopher E. Pelt, MD
      9. THA patients with Fixed Spinopelvic Alignment from Standing to Sitting at Higher Risk of Hip Dislocation
         Seth A. Jerabek, MD
      10. Lumbar Fusion Involving the Sacrum Increases Dislocation Risk 8-Fold in Total Hip Arthroplasty
          Kevin I. Perry, MD
      11. Short-Term Complication Rates Following Outpatient Total Hip Replacement Equivalent or Better Than Those of Inpatient Total Hip Replacement with the Implementation of Institutional Protocols
          Mitchell C. Weiser, MD
      12. Home Health Services are not Required Following Total Hip Arthroplasty
          Roy I. Davidovitch, MD
      13. Pre-Operative Opioid Use Independently Predicts Increased Risk of Early Revision of THA
          Nicholas A. Bedard, MD
      14. When do Patient Reported Outcome Scores Peak After Primary Unilateral TKR and THR?
          David C. Ayers, MD
      15. A Decade of Protocol Developments for SSI Prevention: Intraoperative Betadine Irrigation Prevails
          Matthew S. Austin, MD
      16. Dual-Agent Antibiotic Prophylaxis Using Single Dose Vancomycin Effectively Reduces Prosthetic Joint Infection Rates with Minimal Renal Toxicity Risk
          John R. Burger, DO
      17. Reduction of Total and Viable Particles in the OR Setting by using Ultraviolet In-Room Air Disinfection and Recirculation Units
          Gannon L. Curtis, MD
      18. Reconsidering the Strategies to Manage Chronic Periprosthetic Total Knee Infections: Using Decision Analytics to Find the Optimal Strategy between One-Stage and Two-Stage Total Knee Revision
          Karan Srivastava, MD
      19. Extended Oral Antibiotic Prophylaxis in High Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate
          R. Michael Meneghini, MD
      20. What is the Optimal Criteria to use for Detecting Prosthetic Joint Infections in Total Joint Arthroplasty?
          Preetesh D. Patel, MD
      21. 90-Day Costs, Reoperations and Readmissions for Primary Total Knee Arthroplasty Patients of Varying BMI Levels
          Edward Vasarhelyi, MD
      22. Cost-Effectiveness of Total Knee Arthroplasty vs. Nonoperative Management in Non-Obese, Overweight, Obese, Severely-Obese, Morbidly-Obese and Super-Obese Patients
          Karthikeyan E. Ponnusamy, MD
      23. Are Medicare’s Comprehensive Care for Joint Replacement Bundled Payments Stratifying Risk Adequately?
          Mark A. Cairns, MD
      24. No Optimal Antibiotic-Free Period Prior to Reimplantation for Periprosthetic Joint Infection
          Timothy L. Tan, MD
      25. Should Medicare Remove Total Knee Arthroplasty from Its Inpatient Only List? A Total Knee Replacement is Not a Partial Knee Replacement
          P. Maxwell Courtney, MD
      26. A Comparison of Relative Value Units in Primary vs. Revision Total Knee Arthroplasty: Which Provides the Better Bang for Your Buck?
          Nipun Sodhi, BA
      27. Fretting Corrosion and Polyethylene Damage Mechanisms in Modular Dual Mobility Total Hip Arthroplasty
          Hannah Spece, BS
      28. What is the Impact of Smoking on Revision Total Hip Arthroplasty?
          John J. Callaghan, MD
      29. High Rate of Failure Following Revision of a Constrained Liner
          Michael D. Hellman, MD
      30. Revision Total Knee Replacement for Arthrofibrosis
          John R. Martin, MD
      31. Revision of UKA to TKA: Is it as Good as a Primary Result?
          Adolf V. Lombardi Jr., MD, FACS
      32. Extensor Mechanism Reconstruction with Synthetic Mesh: Large Series of 77 Total Knee Arthroplasties
          Matthew P. Abdel, MD
      33. Does a Balanced TKA Produce a More Forgotten Joint?
          Thomas L. Bradbury, MD
      34. Cell Count and Differential of Aspirated Fluid in Immunosuppressed Patients in the Diagnosis of Total Knee Arthroplasty Prosthetic Joint Infections: A Case Series
          David W. Fitz, MD
      35. A Computer Model of Mid-Flexion Instability in Balanced Cruciate Retaining or Posterior Stabilized Total Knee Arthroplasty
          Ran Schwarzkopf, MD
      36. Total Knee Arthroplasty in the Osteoporotic Tibia:  A Biomechanical Evaluation of the Role of Stem Extensions and Cementing Techniques
          Christopher P. Walsh, MD
      37. High Rate of Early Revision Following Custom Made Unicondylar Knee Replacement
          Carl T. Talmo, MD
      38. Results of Cemented vs. Cementless Primary Total Knee Arthroplasty Using the Same Implant Design
          Anthony W. Feher, MD
      39. Association between Pseudotumor Formation and Patient Factors in Metal-on-Metal Total Hip Arthroplasty Population
          Daniel E. Goltz, BS
      40. Mechanical Complications Following Total Hip Arthroplasty Based on Surgical Approach: A Large Single Institution Cohort Study
          Majd Tarabichi, MD
      41. This paper was not presented in the program.
      42. Early Outcomes of Revision Surgery for Head-Neck Taper Corrosion of Metal-on-Polyethylene THA with Pseudotumors in 43 Patients
          Young-Min Kwon, MD
      43. Impaction Force Influences Taper-Trunnion Stability in Total Hip Arthroplasty
          Jonathan R. Danoff, MD
      44. Intraoperative Evaluation of Acetabular Cup Position During Anterior Approach Total Hip Arthroplasty: Are We Accurately Interpreting?
          Dimitri E. Delagrammaticas, MD
      45. Impingement-free Hip Range of Motion in Asymptomatic Young Adult Females
          Michael C. Mahan, MD
      46. Does Severity of Dysplasia Influence Clinical Outcomes Following the Periacetabular Osteotomy (PAO)? A Case Control Study
          Christopher L. Peters, MD
      47. The Fate of the Contralateral Hip in Patients Undergoing a Periacetabular Osteotomy: Are there Risk Factors for Disease Progression?
          John C. Clohisy, MD
      48. Are There Disease-Specific Articular Cartilage Wear Patterns in Various Pre-Arthritic Hip Disorders?
          Cecilia Pasquale Garrido, MD
      49. Mid-Term Results of Patients Treated with Porous Tantalum Acetabular Components for  Non-Primary Periacetabular Lesions
          David G. Lewallen, MD
      50. Do Focal Chondral Defects Lead to Worse Outcomes after Periacetabular Osteotomy?
          Rafael Sierra, MD
      51. Two-Year Results of a Randomized Trial of Robotic Surgical Assistance vs. Manual Unicompartmental Knee Arthroplasty
          Bryn Jones, MD, FRCS (ORTHO)
      52. Patients at Risk: Preoperative Opioid Use Affects Opioid Prescribing, Refills and Outcomes after Total Knee Arthroplasty
          Nicholas M. Hernandez, MD
      53. Effectiveness of Novel Adjuncts in Multimodal Pain Management Following Total Knee Arthroplasty
          Juan C. Suarez, MD
      54. Factors Influencing Reoperation of Total Knee Arthroplasty in Vasculopathic Patients
          Maxwell K. Langfitt, MD
      55. Formal Physical Therapy May Not Be Essential Following Unicompartmental Knee Arthroplasty:  A Randomized Clinical Trial
          Brian T. Darrith, MD
      56. Novel Immuno-Based Microbial ID Assays for Organism Detection in Synovial Fluid
          Carl A. Deirmengian, MD

Symposium Abstracts in Numeric Order of Presentation

I. Through the Looking Glass: What Does the Future Hold for Arthroplasty?
Moderator: Mark I. Froimson, MD, MBA

II. Lessons Learned from Effective Models of Joint Replacement Care in the United States
Moderator: Christopher L. Peters, MD

III. Prevention and Treatment of Instability Following THA: A Case-Based Symposium
Moderator: Fares S. Haddad, MD, FRCS

V. Managing the Opioid Epidemic
Moderator: William A. Jiranek, MD

VI. Choices, Compromises, and Controversies in Total Knee Arthroplasty
Moderator: Adolf V. Lombardi Jr., MD, FACS

VII. The New Disease: Taper Corrosion After THA – A State of the Art 2017 Update for AAHKS Members
Moderator: Daniel J. Berry, MD

VIII. New Technologies in Knee Replacement
Moderator: Robert M. Molloy, MD